Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr-Jun;10(2):58-64.

1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication

Affiliations

1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication

N A Nikitenko et al. Acta Naturae. 2018 Apr-Jun.

Abstract

Adenovirus infections are characterized by widespread distribution. The lack of causal therapy, which is effective in treating this group of diseases, explains the need for new therapeutic drugs. Notably, anti-adenoviral activity of [4-(phenoxy)benzyl]-5-(phenylamino)-6-azauracil, 1-[4-(phenoxy)benzyl]-5-(morpholino) uracil, 1-[4-(4-chlorophenoxy)benzyl]-5-(morpholino) uracil, and 1-[4-(4-fluorophenoxy)-benzyl]-5-(morpholino) uracil was observed.

Keywords: 5-aminouracil derivatives; Human adenovirus; adenovirus replication; inhibitors of adenovirus replication.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scheme for the synthesis of 1-[4-(phenoxy)benzyl]- 5-(phenylamino)-6-azauracil (1), 1-[4-(phenoxy)benzyl]-5-[(3,5- dichlorophenyl)amino]-6-azauracil (2), and 1-[4-(phenoxy)benzyl]- (3), 1-[4-(4-chlorophenoxy) benzyl]-(4), 1-[4-(4-fluorophenoxy) benzyl]-5-(morpholino)uracil derivatives (5).
Fig. 2
Fig. 2
Scheme for the synthesis of 5-(morpholino)uracil derivatives 6–8
Fig. 3
Fig. 3
Assessment of the relative HAdV5-eGFP genome copy number in HEK293 cells treated with the test compounds. The differences between experimental and control samples were statistically significant at * p < 0.05; *** p < 0.001.
Fig. 4
Fig. 4
Anti-adenoviral activity of 5-aminouracil derivatives. TC50 and IC50 of compounds 1 (A) and 3 (B). Differences between experimental and control samples were statistically significant at * p < 0.05; *** p < 0.001.
Fig. 5
Fig. 5
The survival of HEK293 cells transduced with HAdV5-eGFP and treated with the 5-aminouracil derivatives 1 and 3. (A) The results were obtained using the MTT assay. 100% corresponds to optical density value of intact HEK293 cells (control sample). All reported values are means of three independent measurements with standard deviations. The differences between experimental and control samples were statistically significant in all cases (p < 0.05). (B) Data was obtained using the resazurin assay. One hundred percent corresponds to the fluorescence intensity of intact HEK293 cells (control sample). All reported values are means of three independent measurements with standard deviations. The differences between DMSO samples and other samples were statistically significant in all cases (p < 0.05). The differences between intact cells samples and samples of group “3” were statistically insignificant.

Similar articles

References

    1. Ghebremedhin B., Eur. J. Microbiol. Immunol. 2014;4(1):26–33. - PMC - PubMed
    1. Gupta P., Tobias J.D., Goyal S., Hervie P., Harris J.B., Sadot E., Noviski N.. J. Intensive Care Med. 2011;26(4):267–272. - PubMed
    1. Lu X., Trujillo-Lopez E., Lott L., Erdman D.D.. J. Clin. Microbiol. 2013;51(4):1089–1093. - PMC - PubMed
    1. Gonzalez-Lopez J.J., Morcillo-Laiz R., Munoz-Negrete F.J.. Arch. Soc. Esp. Oftalmol. 2013;88(3):108–115. - PubMed
    1. Eckardt A.J., Baumgart D.C.. Recent Pat Antiinfect Drug Discov. 2011;6(1):54–63. - PubMed

LinkOut - more resources